Skip to main content

Advertisement

Log in

Dendritic Cells Pulsed with Total Tumor RNA for Activation NK-like T Cells Against Glioblastoma Multiforme

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Dendritic cells (DCs) are potent antigen presenting cells and play critical role in T cell-mediated immunity. DCs have been shown to induce strong anti-tumor responses both in vitro and in vivo. Their efficacies in tumor therapy are being investigated in clinical trials. Previous evidence has shown that these DCs enhance the cytotoxicity of NK cells. We generated NK-like T cells (CD3+CD56+), a novel type of effector cells differentiated from normal lymphocyte, which is now being used for adoptive immunotherapy in clinical trials. This study aimed to elucidate the effects of NK-like T cells after co-culturing with DCs against tumor cells. The result revealed that tumor-derived RNA-pulsed DCs can enhance the immune responses of NK-like T cells against glioblastoma multiforme cell line but these effector cells did not appear to have the cytotoxic effect against normal cells (human umbilical vein endothelial cells (HUVEC) and fibroblasts) in vitro. This study may be beneficial for the development of new immunologic effector cells for using in adoptive immunotherapy for glioblastoma multiforme in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. MD Walker E Alexander WE Hunt (1978) ArticleTitleEvaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative trial J Neurosurg 49 333–343 Occurrence Handle355604

    PubMed  Google Scholar 

  2. MD Walker SB Green DP Byar EJ Alexander U Batzdorf WE Hunt CS MacCarty MS Mahaley JJ Mealy G Owens JI Ransahoff JT Robertson WR Shapiro KRJ Smith CB Wilson TA Strike (1980) ArticleTitleRandomized comparisons of radiotherapy and nitrosureas for the treatment of malignant gliomas after surgery N Engl J Med 303 1323–1329 Occurrence Handle7001230

    PubMed  Google Scholar 

  3. LM DeAngelis PC Burger SB Green JG Cairncross (1998) ArticleTitleMalignant glioma: who benefits from adjuvant chemotherapy? Ann Neurol 44 691–695 Occurrence Handle10.1002/ana.410440418 Occurrence Handle9778271

    Article  PubMed  Google Scholar 

  4. L Fong E Engleman (2000) ArticleTitleDendritic cells in cancer immunotherapy Ann Rev Immunol 18 767–811 Occurrence Handle10.1146/annurev.immunol.18.1.245

    Article  Google Scholar 

  5. D Bell J Young J Banchereau (1999) ArticleTitleDendritic cells Adv Immunol 72 225–324

    Google Scholar 

  6. C Milazzo VL Reichardt MR Muller F Grunebach P Brossart (2003) ArticleTitleInduction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA Blood 101 997–982 Occurrence Handle10.1182/blood-2002-04-1273

    Article  Google Scholar 

  7. A Heiser MA Maurice DR Yancey NZ Wu P Dahm SK Pruitt D Boczkowski SK Nair MS Ballo E Gilboa J Vieweg (2001) ArticleTitleInduction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA J Immunol 166 2953–2960 Occurrence Handle11207244

    PubMed  Google Scholar 

  8. WE Schmitt MJ Stassar W Schmitt M Little B Cochlovius (2001) ArticleTitleIn vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells J Cancer Res Clin Oncol 127 203–206 Occurrence Handle10.1007/s004320000201 Occurrence Handle11260867

    Article  PubMed  Google Scholar 

  9. DM Ashley B Faiola S Nair LP Hale DD Bigner E Gilboa (1997) ArticleTitleBone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors J Exp Med 186 1177–1182 Occurrence Handle10.1084/jem.186.7.1177 Occurrence Handle9314567

    Article  PubMed  Google Scholar 

  10. D Boczkowski SK Nair JH Nam HK Lyerly E Gilboa (2000) ArticleTitleInduction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells Cancer Res 60 1028–1034 Occurrence Handle10706120

    PubMed  Google Scholar 

  11. GD Schmidt-Wolf RS Negrin IG Schmidt-Wolf (1997) ArticleTitleActivated T cells and cytokine-induced CD3+CD56+ killer cells Ann Hematol 74 51–56 Occurrence Handle10.1007/s002770050257 Occurrence Handle9063373

    Article  PubMed  Google Scholar 

  12. RE Schmidt C Murray JF Daley SF Schlossman J Ritz (1986) ArticleTitleA subset of natural killer cells in peripheral blood displays mature T cell phenotype J Exp Med 164 351–356 Occurrence Handle10.1084/jem.164.1.351 Occurrence Handle3088199

    Article  PubMed  Google Scholar 

  13. LL Lanier AM Le CI Civin MR Loken JH Phillips (1986) ArticleTitleThe relationship of CD 16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes J Immunol 136 4480–4486 Occurrence Handle3086432

    PubMed  Google Scholar 

  14. JR Ortaldo RT Winkler-Pickett H Yagita HA Young (1991) ArticleTitleComparative studies of CD3+- and CD3+CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression Cell Immunol 136 486–495 Occurrence Handle10.1016/0008-8749(91)90369-M Occurrence Handle1714795

    Article  PubMed  Google Scholar 

  15. P Lu R Negrin (1994) ArticleTitleA novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with SCID J Immunol 153 1678–1696

    Google Scholar 

  16. MR Verneris M Kornacker V Mailander RS Negrin (2000) ArticleTitleResistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis Cancer Immunol Immunother 49 335–345 Occurrence Handle10.1007/s002620000111 Occurrence Handle10946816

    Article  PubMed  Google Scholar 

  17. C Hoyle CD Bangs P Chang O Kamel B Mehta RS Negrin (1998) ArticleTitleExpansion of Philadelphia chromosome-negative CD3+CD56+ cytotoxic cells from chronic myeloid leukemic patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice Blood 92 3318–3327 Occurrence Handle9787169

    PubMed  Google Scholar 

  18. P Lefterova F Schakowski P Buttgereit C Scheffold D Huhn IG Schmidt-Wolf (2000) ArticleTitleExpansion of CD3+CD56+ cytotoxic cells from patients with chronic lymphocytic leukemia: in vitro efficacy Haematologica 104 72–79 Occurrence Handle10.1159/000039755

    Article  Google Scholar 

  19. IG Schmidt-Wolf S Finke B Trojaneck A Denkena P Lefterova N Schwella HG Heuft G Prange M Korte M Takeya T Dorbic A Neubauer B Wittig D Huhn (1999) ArticleTitlePhase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma Br J Cancer 81 1009–1016 Occurrence Handle10.1038/sj.bjc.6690800 Occurrence Handle10576658

    Article  PubMed  Google Scholar 

  20. D Valteau-Couanet C Leboulaire K Maincent M Tournier O Hartmann J Benard F Beaujean C Boccaccio L Zitvogel E Angevin (2002) ArticleTitleDendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients Blood 100 2554–2561 Occurrence Handle10.1182/blood.V100.7.2554 Occurrence Handle12239169

    Article  PubMed  Google Scholar 

  21. A Marten S Renoth M Lilienfeld-Toal Particlevon P Buttgereit F Schakowski A Glasmacher T Sauerbruch IG Schmidt-Wolf (2001) ArticleTitleEnhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells Haematologica 86 1029–1037 Occurrence Handle11602408

    PubMed  Google Scholar 

  22. C Ziske A Marten B Schottker P Buttgereit F Schakowski M Gorschluter A Rucker Particlevon C Scheffold N Chao T Sauerbruch IG Schmidt-Wolf (2001) ArticleTitleResistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA19–9 Mol Ther 3 54–60 Occurrence Handle10.1006/mthe.2000.0230 Occurrence Handle11162311

    Article  PubMed  Google Scholar 

  23. P Brossart F Grunebach G Stuhler VL Reichardt R Mohle L Kanz W Brugger (1998) ArticleTitleGeneration of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor Blood 92 4238–4247 Occurrence Handle9834229

    PubMed  Google Scholar 

  24. IG Schmidt-Wolf P Lefterova V Johnston D Huhn KG Blume RS Negrin (1994) ArticleTitlePropagation of large numbers of T cells with natural killer cell markers Br J Haematol 87 453–458 Occurrence Handle7527643

    PubMed  Google Scholar 

  25. CM Celluzzi JI Mayordomo WJ Storkus MT Lotze LD Falo SuffixJr. (1996) ArticleTitlePeptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity J Exp Med 183 283–287 Occurrence Handle10.1084/jem.183.1.283 Occurrence Handle8551233

    Article  PubMed  Google Scholar 

  26. A Porgador E Gliboa (1995) ArticleTitleBone marrow-generated dendritic cells pulsed with class I-restricted peptide are potent inducers of cytotoxic T lymphocytes J Exp Med 182 255–260 Occurrence Handle10.1084/jem.182.1.255 Occurrence Handle7540653

    Article  PubMed  Google Scholar 

  27. HT Ni SR Spellman WC Jean WA Hall WC Low (2001) ArticleTitleImmunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial glioma J Neuro-oncol 51 1–9 Occurrence Handle10.1023/A:1006452726391

    Article  Google Scholar 

  28. SA Rosenberg (1999) ArticleTitleA new era for cancer immunotherapy based on the genes that encode cancer antigens Immunity 10 281–287 Occurrence Handle10.1016/S1074-7613(00)80028-X Occurrence Handle10204484

    Article  PubMed  Google Scholar 

  29. J Gong D Chen M Kashiwaba D Kufe (1997) ArticleTitleInduction of antitumor activity by immunization with fusion of dendritic cell and carcinoma cells Nat Med 3 558–561 Occurrence Handle10.1038/nm0597-558 Occurrence Handle9142127

    Article  PubMed  Google Scholar 

  30. KD Kim SC Choi A Kim YK Choe IS Choe JS Lim (2001) ArticleTitleDendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction Int Immunopharmacol 1 2117–2129 Occurrence Handle10.1016/S1567-5769(01)00137-0 Occurrence Handle11710541

    Article  PubMed  Google Scholar 

  31. J Schmidt S Eisold MW Buchler A Marten (2004) ArticleTitleDendritic cells reduce number and function of CD4(+)CD25(+) cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma Cancer Immunol Immunother 253 1018–1026

    Google Scholar 

  32. H Nishikawa T Kato K Tanida A Hiasa I Tawara H Ikeda Y Ikarashi H Wakasugi M Kronenberg T Nakayama M Taniguchi K Kuribayashi LJ Old H Shiku (2003) ArticleTitleCD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses Proc Natl Acad Sci USA 100 10902–10906 Occurrence Handle10.1073/pnas.1834479100 Occurrence Handle12947044

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Suradej Hongeng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vichchatorn, P., Wongkajornsilp, A., Petvises, S. et al. Dendritic Cells Pulsed with Total Tumor RNA for Activation NK-like T Cells Against Glioblastoma Multiforme. J Neurooncol 75, 111–118 (2005). https://doi.org/10.1007/s11060-005-2317-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-005-2317-2

Keywords

Navigation